Mirum Pharmaceuticals, Inc.MIRMNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$13.96M
↑ 121% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
$-66.45M
Historical baseline
PeriodValueYoY Change
TTM$13.96M+128.5%
2024$-48.97M+64.1%
2023$-136.49M-11.1%
2022$-122.85M-87.9%
2021$-65.39M+36.1%
2020$-102.31M-96.0%
2019$-52.21M-201.2%
2018$-17.33M-